Overview
News
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$39.5M
1 round on record
Latest round
$39.5M
Venture round · Mar 2026 · 6 mo ago
Team
11-50
employees, estimated range
Backers
3
Angelini Ventures, Lumira Ventures
The money's age
Fresh money
6 months since the last round · not hiring
Momentum
20/100
fresh money
Last sign of life
this month
a posting or a news item
Funding rounds
RoundDateAmountInvestorsSource
Venture round Mar 2026 $39.5M — prnewswire.com
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
Nextmol develops computational chemistry and artificial intelligence solutions for chemical R&D. Discover the platform that L'Oreal and…
RowanFounded 2023
Rowan is a cloud-based computational chemistry platform for molecular property prediction, simulation, and protein–ligand complex modeling…
Streamline discovery with our integrated drug discovery platform, blending AI, physics-based tools, and wet lab for unparalleled…
Iambic TherapeuticsConvertible Note $75k · 2 yr ago • Founded 2019
Iambic Therapeutics combines machine learning with automated chemistry to discover small molecule drugs. Its NeuralPLexer models predict…
PARIMA51-200 employees
PARIMA builds the future of protein through advanced cell cultivation.
Gandeeva51-200 employees
Gandeeva Therapeutics is a precision medicine company leveraging cryo-EM and machine learning for drug discovery.

Overview

We are a drug discovery company that is uniquely harnessing the power of protein dynamics, biophysics, machine learning and computational chemistry.

News

Press release 5 months ago
Congruence Announces Participation at the 2026 Bloom Burton & Co. Healthcare Investor Conference
https://www.prnewswire.com/news-releases/congruence-announces-participation-at-the-2026-bloom-burton-co-healthcare-investor-conference-302747214.html The post Congruence Announces Participation at the 2026 Bloom Burton & Co. Healthcare Investor Conference
Read more
Report
Press release 5 months ago
Congruence Announces Participation in the 25th Annual Needham Virtual Healthcare Conference
https://www.prnewswire.com/news-releases/congruence-announces-participation-in-the-25th-annual-needham-virtual-healthcare-conference-302738712.html?tc=eml_cleartime The post Congruence Announces Participation in the 25th Annual Needham Virtual Healthcare
Read more
Report
Press release 6 months ago
Congruence Announces $39.5M Financing to Advance Portfolio of Small Molecule Correctors into the Clinic
https://www.prnewswire.com/news-releases/congruence-announces-39-5m-financing-to-advance-portfolio-of-small-molecule-correctors-into-the-clinic-302718764.html?tc=eml_cleartime The post Congruence Announces $39.5M Financing to Advance Portfolio of Small Mo
Read more
Report
Blog 6 months ago
Congruence annonce un financement de 39,5 millions de dollars pour faire passer son portefeuille de correcteurs à petites molécules au stade clinique
Essai clinique de phase 1/1b en cours avec le CGX-926 pour l'obésité génétique liée à un déficit en MC4R Programmes sur la maladie de Parkinson et le déficit en alpha-1-antitrypsine avancent vers la phase clinique Montréal, Canada, le 19 mars 2026 - Congr
Read more
Report
Press release 6 months ago
Congruence Announces First Dosing in Phase 1/1b Clinical Trial of CGX-926, a First-in-Class Oral MC4R Corrector for Genetic Obesity
https://www.prnewswire.com/news-releases/congruence-announces-first-dosing-in-phase-11b-clinical-trial-of-cgx-926-a-first-in-class-oral-mc4r-corrector-for-genetic-obesity-302718759.html?tc=eml_cleartime The post Congruence Announces First Dosing in Phase
Read more
Report
Pro access
Upgrade to see all 25 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.

Financials

Total raised
$39.5M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
Round Announced Amount
Venture - Series Unknown 2026 $39.5M Details